Central Carolina Nephrology is categorized under Nephrologists in Concord, NC and active since 2010.
Central Carolina Nephrology was established in 2010, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Nephrologists business, which does work in the B2C market, and is classified as a Nephrologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Pam Meisser, Office Manager at the company’s single location by writing to 433 Copperfield Boulevard Ne, Concord, North Carolina NC 28025 or by phoning (704) 786-7770. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Central Carolina Nephrology |
Contact Person: | Pam Meisser, Office Manager |
Address: | 433 Copperfield Boulevard Ne, Concord, North Carolina 28025 |
Phone Number: | (704) 786-7770 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Nephrologists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Central Carolina Nephrology was started in 2010 to provide professional Nephrologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Pam Meisser, Office Manager for inquiries that concern Central Carolina Nephrology by calling the company number (704) 786-7770, as your correspondence is most welcome. Additionally, the physical location of the single location of Central Carolina Nephrology can be found at the coordinates 35.44989,-80.59374 as well as the street address 433 Copperfield Boulevard Ne in Concord, North Carolina 28025.
For its online presence, you may visit Central Carolina Nephrology’s website at and engage with its social media outlets through on Twitter and on Facebook.